MedTrace Logo

Leveraging Plasma Concentration Levels to Optimize Extracorporeal Treatment in Acute Diquat Poisoning

NCT06807151 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 163

Last updated 2025-04-22

No results posted yet for this study

Summary

This study aimed to evaluate the clinical value of plasma diquat concentration in guiding personalized extracorporeal treatment regimens for patients with acute diquat poisoning.

Conditions

  • Diquat Poisoning
  • Blood Purification

Interventions

PROCEDURE

Extracorporeal Treatment

Extracorporeal treatments in our study included hemoperfusion and continuous veno-venous hemodiafiltration.

Sponsors & Collaborators

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2023-07-31
Completion
2025-04-12

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06807151 on ClinicalTrials.gov